The Correlation Between Angiotensin II Levels and Homeostatic Model Assessment of Insulin Resistance in Normotensive Young Adults with a Family History of Essential Hypertension
Keywords:
Normotensive, offspring essential hypertension, angiotensin II, HOMA-IRAbstract
Background: A family history of hypertension increases the risk of renin–angiotensin–aldosterone system activation, insulin resistance, and vascular inflammation, contributing to cardiovascular disease. Early vascular disturbances, marked by angiotensin II and insulin resistance assessed through the homeostatic model assessment of insulin resistance (HOMA-IR), play crucial roles in hypertension development. This study aims to determine the comparison and correlation between Ang II levels and HOMA-IR in normotensive young adults with or without offspring hypertension. Methods: We conducted this cross-sectional study by recruiting fifty normotensive participants, who were categorized into two groups: normotensive young adults who are offspring of parents with essential hypertension (case) and those who are not (control). The serum Ang II and HOMA-IR were measured. The comparative analysis was conducted using the Mann-Whitney test, and correlations were evaluated using Spearman’s test. Results: Among the 50 subjects (25 cases and 25 controls), a significant difference was observed in Ang II levels (p = 0.010), whereas HOMA-IR (p = 0.206) showed no notable difference between case and control. Notably, a positive correlation between Ang II and HOMA-IR (r = 0.554; p = 0.004) was observed in the case group, while the control group exhibited an insignificant correlation (r = –0.089; p = 0.671). Conclusion: There are marked differences in Ang II levels between normotensive young adults with a family history of essential hypertension and those without such history. Additionally, a significant correlation was found between Ang II and HOMA-IR in normotensive young adults who have a family history of essential hypertension.References
Cardiovascular diseases (CVDs) [Internet]. [cited 2024 Nov 4]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Stokes J, Kannel WB, Wolf PA, D’Agostino RB, Adrienne Cupples L. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension [Internet]. 1989;13(5 Suppl):I-13-I–18. Available from: https://pubmed.ncbi.nlm.nih.gov/2535213/
Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens [Internet]. 1995 Dec 1;13:1546–59. Available from: https://europepmc.org/article/med/8903608
Brasher VJ. Alterations of cardiovascular function. Pathophysiology: The biologic basis for disease in adults and children. Elsevier Health Sciences; 2014. p. 1129–93.
Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol [Internet]. 2016 May 1 [cited 2024 Nov 4];32(5):659–68. Available from: https://pubmed.ncbi.nlm.nih.gov/27118293/
Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM. Angiotensin II and vascular injury. Curr Hypertens Rep [Internet]. 2014;16(6). Available from: https://pubmed.ncbi.nlm.nih.gov/24760441/
Sharma A, Misra R, Singh K. Comparison of cardiac autonomic activity between offsprings of normotensive parents and hypertensive parents. International Journal of Integrative Medical Sciences [Internet]. 2018 Oct 10;5(8):715–20. Available from: http://imedsciences.com/ijims-2018-128
Muscogiuri G, Chavez A, Gastaldelli A, et al. The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol [Internet]. 2008 Sep 30;6(4):301–12. Available from: https://pubmed.ncbi.nlm.nih.gov/18855718/
Zhou MS, Schulman IH, Zeng Q. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease. Vasc Med [Internet]. 2012 Oct;17(5):330–41. Available from: https://pubmed.ncbi.nlm.nih.gov/22814999/
Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol [Internet]. 1997;59:395-412. Available from: https://pubmed.ncbi.nlm.nih.gov/9074770/
Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) [Internet]. 2010;7. Available from: https://pubmed.ncbi.nlm.nih.gov/20374655/
Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci [Internet]. 2008 Jul;29(7):367–74. Available from: https://pubmed.ncbi.nlm.nih.gov/18579222/
Motta JM, Lemos TM, Consolim-Colombo FM, et al. Abnormalities of anthropometric, hemodynamic, and autonomic variables in offspring of hypertensive parents. j clin hypertens (Greenwich) [Internet]. 2016 Sep 1;18(9):942–8. Available from: https://pubmed.ncbi.nlm.nih.gov/26935870/
Kučerová J, Filipovský J, Staessen JA, et al. Arterial characteristics in normotensive offspring of parents with or without a history of hypertension. Am J Hypertens [Internet]. 2006 Mar [cited 2024 Nov 4];19(3):264–9. Available from: https://pubmed.ncbi.nlm.nih.gov/16500511/
Mamenko M, Zaika O, Prieto MC, et al. Chronic angiotensin II infusion drives extensive aldosterone-independent epithelial Na+ channel activation. Hypertension [Internet]. 2013;62(6):1111–22. Available from: https://pubmed.ncbi.nlm.nih.gov/24060890/
Catt KJ, Zimmet PZ, Cain MD, Cran E, Best JB, Coghlan JP. Angiotensin II blood levels in human hypertension. Lancet [Internet]. 1971 Mar 6;1(7697):459–64. Available from: https://pubmed.ncbi.nlm.nih.gov/4100346/
Busse LW, McCurdy MT, Ali O, Hall A, Chen H, Ostermann M. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature. Crit Care [Internet]. 2017 Dec 28;21(1). Available from: https://pubmed.ncbi.nlm.nih.gov/29282149/
Semple RK. EJE PRIZE 2015: How does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur J Endocrinol [Internet]. 2016 May 1;174(5):R209–23. Available from: https://pubmed.ncbi.nlm.nih.gov/26865583/
Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Pathophysiology of physical inactivity-dependent insulin resistance: A theoretical mechanistic review emphasizing clinical evidence. J Diabetes Res [Internet]. 2021;2021:7796727. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8516544/
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Molecular mechanisms linking stress and insulin resistance. EXCLI J [Internet]. 2022 Jan 3;21:317-34. Available from: https://pubmed.ncbi.nlm.nih.gov/35368460/
Rice MM, Landon MB, Varner MW, et al. Pregnancy-associated hypertension and offspring cardiometabolic health. Obstetrics and Gynecology [Internet]. 2018 Feb 1;131(2):313–21. Available from: https://pubmed.ncbi.nlm.nih.gov/29324603/
Montagnani M, Ravichandran L V., Chen H, Esposito DL, Quon MJ. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol [Internet]. 2002;16(8):1931–42. Available from: https://pubmed.ncbi.nlm.nih.gov/12145346/
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol [Internet]. 2018 Aug 31;17(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30170598/
Mino D, Wacher N, Amato D, Búrbano G, Fonseca ME, Revilla C, et al. Insulin resistance in offspring of hypertensive subjects. J Hypertens [Internet]. 1996;14(10):1189–93. Available from: https://pubmed.ncbi.nlm.nih.gov/8906517/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stella Palar, Haerani Rasyid, Syarif Bakri, Idar Mappangara

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
